Aultman Hospital Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2004
NCT00315211
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Aultman Cancer Center at Aultman Hospital | Aultman Hospital- Interventional Radiologist

Active Ingredients

Drugs in Phase 4 Trials (1)

ethyl chloride (1 trial)

Drugs in Phase 2 Trials (2)

docetaxel (taxotere) (1 trial)

topotecan (hycamtin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Lung Neoplasms (Phase 2)

Mediastinal Neoplasms (Phase 2)

Small Cell Lung Carcinoma (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3